Buradasınız

Anasayfa » Content

Effect of p-chlorophenylalanine pretreatment on sodium valproate and dexfenfluramine induced wet dog shake behavior in rats

Effect of p-chlorophenylalanine pretreatment on sodium valproate and dexfenfluramine induced wet dog shake behavior in rats

Journal Name:

  • Indian Journal of Basic & Applied Medical Research

Publication Year:

  • 2012

Key Words:

Author Name
Abstract (2. Language): 
INTRODUCTION: Sodium valproate, a broad spectrum antiepileptic drug elevates the brain gamma amino butyric acid (GABA) levels by various mechanisms. Behavioral studies in animals have provided additional evidence for interaction between the GABAergic and DAergic systems. Valproate at 200 -500mg/kg induces wet dog shake (WDS) behavior in rats. The WDS behavior in rats and head twitch responses (HTR) in mice is evoked by 5- hydroxytryptamine (5-HT, serotonin), the 5-HT precursor, the directly acting non-selective 5-HT receptor agonists and 5-HT releasers. METHOD: In order to determine the GABAergic and 5-HTergic involvement in the induction of WDS behavior in rats the study was taken up to investigate the effect of clomipramine a 5HT depletor, pretreatment on sodium valproate, dexfenfluramine and 5-hydroxytrytamine (5-HTP) induced WDS behavior in rats. OBSERVATION: It was observed that Valproate in the dose range of 200-500mg/kg induced dose dependent WDS in rats. RESULTS: It was observed that pretreatment with PCPA significantly decreased the number of head and whole body shakes in rats caused by valproate and dexfenfluramine. This indicates that the induction of WDS behavior by valproate depends on the availability of brain 5HT and that valproate acts indirectly by releasing 5HT from the 5HTergic neurons.
Bookmark/Search this post with
FULL TEXT (PDF): 
PDF icon arastirmax-effect-p-chlorophenylalanine-pretreatment-sodium-valproate-and-dexfenfluramine-induced-wet-dog-shake-behavior-rats.pdf
  • 3
209-213
  • Turkish

REFERENCES

References: 

1. Phillips and Fowler. LJ: “The effects of sodium
valproate on gamma-amino butyrate metabolism
and behavior in naive and ethanolamine-0-
sulphate pretreated rats and
mice”. Biochem. Pharmacol. 1982, J/: 2257-2261
2. Chapman, AG, Keane, PE, Meldrum, BS,
Simiand, J., and Vernieres, JC: “Mechanism of
anticonvulsant action of
valproate”. Prog. Neurobiol: 1982:19, 315-359
3. Racagni, G.; Bruno, F.; Cattabeni, F, et al:
“Functional interaction between rat substantia
nigra and striatum: GABA and dopamine
interrelation”. Brain Res. 1977,
134:353- 358
4. Guidotti A, Gale K, Hong J, Toffano G;
In:”Interactions between putative
neurotransmitters in the brain”, (Garattini S, Pujol
JF, Samanin S.Eds), 1978, p217, Raven Press,
New York.
5. Worms, P. Willigens, MT, and Lloyd, KG:
“GABA involvement in neuroleptic-induced
catalepsy”. J. Pharm. Pharmacol, 1978. 30:716-
718
6. Balsara, JJ, Jadhav, JH & Chandorkar, AG:” Effect of
drugs influencing central serotonergic mechanisms on
haloperidol-induced catalepsy”. Psychopharmacology,
1979, 22, 67-69.
7. Zifa E. Fillion G:“5-Hydroxytryptamine
receptors”. Pharmacol Rev, 1992, 44:401-458.
8. Yap CY, Taylor DA: “Involvement of 5-HT2
receptors in the wet-dog shake behavior induced by 5-
hydroxytryptophan in the rat”.Neuropharmacology,
1983, 22:801–804.
9. Koe BK, and Weissman A:” P-Chlorophenylalanine:
A specific depletor of brain serotonin”. J. Pharmacol.
Exp. Ther, 1966,154, 499–516.
10. Fletcher, V.Harding-:“Investigations into the mode of
action of the anticonvulsant drug sodium valproate”,
J. Pharm. Pharmacol, 1981, vol. 33, no. 12, p. 811-
813.

Thank you for copying data from http://www.arastirmax.com